INTENSITY THERAPEUTICS, INC.

Nasdaq:INTS

Biological Products, (No Diagnostic Substances)·SHELTON, CT

CFO

Wesolowski John M

Financials

11 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	3/13/25	→
10-Q	Q3 2024	9/30/24	11/13/24	→
10-Q	Q2 2024	6/30/24	8/8/24	→
↓

Earnings Releases (8-K)

11 shown

Filed	Period
3/5/26	Q1 FY2026	→
11/6/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
5/13/25	Q2 FY2025	→
3/13/25	Q1 FY2025	→
11/13/24	Q4 FY2024	→
↓

News (8-K)

29 shown

Filed	Type	Description
3/6/26	Other	Other Events	→
2/13/26	Other	Material Modification to Rights of Security Holders	→
12/5/25	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
12/4/25	Other	Other Events	→
10/31/25	Agreement	Entry into a Material Definitive Agreement	→
10/23/25	Vote	Submission of Matters to a Vote of Security Holders	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
1/23/26	S-8	S-8	→
12/4/25	424B5	424B5	→
11/3/25	424B5	424B5	→
6/27/25	S-8	S-8	→
6/18/25	424B5	424B5	→
6/12/25	424B5	424B5	→
↓

Filing History(221 filings)

TypeDateAccessionPeriodSize

8-K

Mar 6, 2026

0001567264-26-0000148-K

Mar 5, 2026

171.3 KB

8-K

Mar 5, 2026

0001567264-26-0000118-K

Mar 5, 2026

282.4 KB

8-K

Feb 13, 2026

0001567264-26-0000078-K

Feb 13, 2026

195.9 KB

S-8

Jan 23, 2026

0001567264-26-000003S-8

—

275.4 KB

Jan 5, 2026

0001895944-26-000003FORM 4

Dec 31, 2025

5.2 KB

Jan 5, 2026

0001524547-26-000003FORM 4

Dec 31, 2025

5.2 KB

8-K

Dec 5, 2025

0001567264-25-0001118-K

Dec 4, 2025

180.4 KB

8-K

Dec 4, 2025

0001567264-25-0001098-K

Dec 4, 2025

225.1 KB

424B5

Dec 4, 2025

0001567264-25-000108424B5

—

9.9 KB

8-K

Nov 6, 2025

0001567264-25-0001048-K

Nov 6, 2025

247.2 KB

10-Q

Nov 6, 2025

0001567264-25-00010310-Q

Sep 30, 2025

4.7 MB

424B5

Nov 3, 2025

0001628280-25-047924424B5

—

500.0 KB

8-K

Oct 31, 2025

0001628280-25-0478558-K

Oct 30, 2025

591.7 KB

8-K

Oct 23, 2025

0001567264-25-0000968-K

Oct 22, 2025

149.8 KB

8-K

Sep 10, 2025

0001567264-25-0000938-K

Sep 10, 2025

142.3 KB

DEFA14A

Sep 9, 2025

0001567264-25-000091DEFA14A

—

1.2 MB

DEF 14A

Sep 9, 2025

0001567264-25-000090DEF 14A

Sep 9, 2025

1.8 MB

PRE 14A

Aug 28, 2025

0001567264-25-000087PRE 14A

Aug 28, 2025

1.8 MB

SCHEDULE 13G/A

Aug 14, 2025

0001172661-25-003586

—

10.4 KB

8-K

Aug 12, 2025

0001567264-25-0000818-K

Aug 8, 2025

161.6 KB

8-K

Aug 7, 2025

0001567264-25-0000788-K

Aug 7, 2025

238.3 KB

10-Q

Aug 7, 2025

0001567264-25-00007710-Q

Jun 30, 2025

4.6 MB

8-K

Aug 4, 2025

0001567264-25-0000718-K

Aug 4, 2025

173.8 KB

8-K

Jul 18, 2025

0001567264-25-0000698-K

Jul 17, 2025

149.0 KB

SCHEDULE 13G/A

Jul 9, 2025

0001951757-25-000597

—

6.6 KB

25 filings shown

INTENSITY THERAPEUTICS, INC.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(221 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
9/9/25	DEFA14A	DEFA14A	→
9/9/25	DEF 14A	DEF 14A	→
8/28/25	PRE 14A	PRE 14A	→
6/2/25	DEFA14A	DEFA14A	→
6/2/25	DEF 14A	DEF 14A	→
6/4/24	DEFA14A	DEFA14A	→
↓

Filed	Form	Description
1/5/26	4	4	→
1/5/26	4	4	→
7/2/25	4	4	→
7/2/25	4	4	→
5/6/25	4	4	→
5/6/25	4	4	→
↓

Filed	Form	Description
8/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
7/9/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
5/15/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
4/24/25	EFFECT	EFFECT	→
3/28/25	DRS	DRS	→
2/14/25	SCHEDULE 13G	SCHEDULE 13G	→
↓